Invention Grant
US08648169B2 Methods of use of Trk receptor modulators 有权
使用Trk受体调节剂的方法

Methods of use of Trk receptor modulators
Abstract:
The present invention relates to methods of treating or preventing retinal ganglion cell (RGC) death and/or glaucoma using modulators of neurotrophic receptors that comprise β-turn peptidomimetic cyclic compounds or derivatives thereof. The neurotrophic receptor modulators can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat or prevent ocular hypertension, RGC death and/or glaucoma.
Public/Granted literature
Information query
Patent Agency Ranking
0/0